New technology in reproductive health
•Non-invasive genetic diagnosis
•Babies free of hereditary diseases
•Gender selection
•Selection of the best embryo
•Fertility preservation
In association with the University of Sonora, we promote postgraduate programs to train experts in Assisted Reproduction through formal higher education programs, such as our Master's Degree in Gynecological Endocrinology and Infertility.
In scientific development it is vital to establish agreements for the training of postgraduate professionals that generate scientific advances. Our collaborators share ideas and knowledge with researchers from institutions such as:
The contributions of our experts and collaborators have been recognized in prestigious international scientific journals and publications. Find out about some of our scientific contributions at:
Nowadays we can avoid chromosomal and genetic defects in the future baby if we analyze the genome of the embryo. We have more than 10 years of experience and vanguard ensuring embryonic normality before the transfer.
For couples carrying a hereditary disease, there is hope; one in four embryos can be normal and free of the familial disease that affects a couple with or without infertility problems. We specialize in finding a personalized solution in each case.
A vitally important issue for women over the age of 35 is that oocyte quality decreases dramatically. We devise and improve, in a personalized way, the diagnosis of ovarian quality and its relationship with embryo viability and success, at the same time as we work to rescue ovarian potential with regenerative treatments to recover the possibility of pregnancy with your own eggs.
In order to determine the days on which the endometrium is apt to receive the embryo and those on which the embryo is most likely to implant correctly, we study the endometrial implantation markers and the molecules secreted by the embryo. This will allow us to determine the exact moment at which the embryo transfer should be carried out and thus increase the embryo implantation rate after an In Vitro Fertilization cycle.
Reproductive medicine at Ingenes improves every day thanks to our training, capacity and experience in the area of clinical research, solving emerging hypotheses with the formal analysis of clinical results. We find solutions and share our knowledge.
Understanding and correctly diagnosing problems with the endometrium that receives and nourishes the embryo is vital to the achievement of pregnancy. We use novel stem cell technology, growth factors and correction of immunological abnormalities for a healthy and productive pregnancy.
Optar por nuestros tratamientos de reproducción asistida en nuestra clínica de reproducción asistida ofrece numerosos beneficios:
Permiso Cofepris: 133300201A1156
Dr. Felipe Camargo Cédula Profesional SEP: 4452501
©Todos los derechos reservados 2024. Instituto Ingenes, Fertilidad & Genética